Guidelines differ on recommendations of statin treatment for African-Americans

March 19, 2017, The JAMA Network Journals

Approximately 1 in 4 African American individuals recommended for statin therapy under guidelines from the American College of Cardiology/American Heart Association are no longer recommended for statin therapy under guidelines from the U.S. Preventive Services Task Force, according to a study published online by JAMA Cardiology. The study is being released to coincide with its presentation at the American College of Cardiology's 66th Annual Scientific Session.

Modern prevention guidelines substantially increase the number of who are eligible for treatment with statins. Efforts to refine statin eligibility via coronary calcification have been studied in white populations but not, to the authors' knowledge, in large African American populations. Venkatesh L. Murthy, M.D., Ph.D., of the University of Michigan, Ann Arbor, and colleagues compared the relative accuracy of U.S. Preventive Services Task Force (USPSTF) and American College of Cardiology/American Heart Association (ACC/AHA) recommendations in identifying African American individuals with subclinical and clinical atherosclerotic (plaque build-up within arteries) cardiovascular disease (ASCVD). African Americans are at disproportionately high risk for ASCVD.

The study included 2,812 African American individuals, ages 40 to 75 years, without prevalent ASCVD, who underwent assessment of ASCVD risk. Of these, 1,743 participants completed computed tomography, and coronary artery calcium (CAC) and abdominal aortic calcium scores were determined.

Among the findings central to prevention efforts:

  • Approximately 1 in 4 African American individuals recommended for under ACC/AHA guidelines are no longer recommended for statin therapy under USPSTF guidelines. Individuals only eligible for statins under ACC/AHA guidelines experienced a low to intermediate event rate, suggesting decreased sensitivity of the USPSTF recommendations in identifying participants at risk of ASCVD. Consequently, USPSTF guidelines focus treatment on a smaller high-risk group (38 percent of high-risk African American individuals) at the expense of missing significant numbers of African American individuals with vascular calcification.
  • While those who were eligible for statins by both USPSTF and ACC/AHA had a similar risk of incident ASCVD (i.e., heart attack, ischemic stroke, or fatal coronary heart disease) compared with non-eligible participants, the addition of CAC scoring improved risk stratification above guideline recommendations, suggesting that CAC has the potential to personalize recommendation for statin therapy by both guideline recommendations.

"Despite debate over the potential cost, risk calibration, and metabolic health implications of increasing statin use, these results support a guideline-based approach to statin recommendation, leveraging targeted imaging (or other surrogate atherosclerotic measures) in African American individuals to further personalize statin-based prevention programs," the authors write.

Explore further: African-Americans may receive different advice on statin therapy

Related Stories

African-Americans may receive different advice on statin therapy

March 19, 2017
African Americans experience a disproportionately high risk of cardiovascular disease, and statin treatment can be an important tool to lower the risk of plaque building up in the arteries.

Prevalence, prognostic implications of coronary artery calcification in women at low CVD risk

November 15, 2016
Among women at low risk of atherosclerotic cardiovascular disease (ASCVD), coronary artery calcium was present in approximately one-third and was associated with an increased risk of ASCVD and modest improvement in prognostic ...

European, American guidelines lead to different recs for statins

September 26, 2016
(HealthDay)—European and American guidelines lead to different recommendations for statin therapy, according to a study published online Sept. 21 in JACC: Cardiovascular Imaging.

Statin use increases substantially in US, although use suboptimal in high-risk groups

November 14, 2016
From 2002 to 2013, the use of statins increased substantially among U.S. adults, although use in high-risk groups remains suboptimal, and there are persistent disparities among women, racial/ethnic minorities, and the uninsured, ...

US, European cholesterol guidelines differ in statin use recommendations

March 29, 2014
Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all ...

Disease-guided approach ups specificity of statin treatment

August 23, 2016
(HealthDay)—A disease-guided approach to statin eligibility can improve treatment specificity, according to a study published in the Aug. 30 issue of the Journal of the American College of Cardiology.

Recommended for you

Heart disease may only be a matter of time for those with healthy obesity

April 24, 2018
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.

A wearable device intervention to increase exercise in peripheral artery disease

April 24, 2018
A home-based exercise program, consisting of wearable devices and telephone coaching, did not improve walking ability for patients with peripheral artery disease, according to a new Northwestern Medicine study.

Women at greater risk of stress-induced ischemia after heart attacks

April 24, 2018
Women who've previously experienced a heart attack have twice the risk of later myocardial ischemia provoked by mental stress when compared to men with a similar history, according to a study published in Circulation.

Electric cars don't jolt implanted heart devices: study

April 24, 2018
(HealthDay)—People who have implanted devices to keep their hearts running smoothly can safely drive an electric car if they wish to do so, new research confirms.

Hippo pathway found essential to orchestrate the development of the heart

April 23, 2018
Using a technology that provides a 'high-resolution view' of the status of individual cells, a team of researchers has gained new insights into the embryonic development of the mouse heart. They discovered that during development, ...

Compound improves stroke outcome by reducing lingering inflammation

April 20, 2018
An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.